Evelo Biosciences Stock Gross Profit
Evelo Biosciences fundamentals help investors to digest information that contributes to Evelo Biosciences' financial success or failures. It also enables traders to predict the movement of Evelo Pink Sheet. The fundamental analysis module provides a way to measure Evelo Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Evelo Biosciences pink sheet.
Evelo |
Evelo Biosciences Company Gross Profit Analysis
Evelo Biosciences' Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
CompetitionAccording to the company disclosure, Evelo Biosciences reported 0.0 of gross profit. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The gross profit for all United States stocks is 100.0% higher than that of the company.
Evelo Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Evelo Biosciences' direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Evelo Biosciences could also be used in its relative valuation, which is a method of valuing Evelo Biosciences by comparing valuation metrics of similar companies.Evelo Biosciences is currently under evaluation in gross profit category among its peers.
Evelo Fundamentals
Return On Equity | -62.33 | ||||
Return On Asset | -0.83 | ||||
Current Valuation | 23.69 M | ||||
Shares Outstanding | 18.93 M | ||||
Shares Owned By Insiders | 0.23 % | ||||
Shares Owned By Institutions | 83.13 % | ||||
Number Of Shares Shorted | 430.1 K | ||||
Price To Earning | (4.19) X | ||||
Price To Book | 3.51 X | ||||
EBITDA | (108.41 M) | ||||
Net Income | (114.53 M) | ||||
Cash And Equivalents | 92.01 M | ||||
Cash Per Share | 0.85 X | ||||
Total Debt | 51.14 M | ||||
Debt To Equity | 1.55 % | ||||
Current Ratio | 4.53 X | ||||
Book Value Per Share | (1.42) X | ||||
Cash Flow From Operations | (101.23 M) | ||||
Short Ratio | 0.42 X | ||||
Earnings Per Share | (15.64) X | ||||
Target Price | 10.0 | ||||
Number Of Employees | 66 | ||||
Beta | 1.74 | ||||
Market Capitalization | 7 M | ||||
Total Asset | 64.44 M | ||||
Retained Earnings | (529.22 M) | ||||
Working Capital | 39.18 M | ||||
Current Asset | 49.29 M | ||||
Current Liabilities | 4.32 M | ||||
Z Score | -16.24 | ||||
Net Asset | 64.44 M |
Pair Trading with Evelo Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Evelo Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evelo Biosciences will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Chevron Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chevron Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chevron Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chevron Corp to buy it.
The correlation of Chevron Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chevron Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chevron Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chevron Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Consideration for investing in Evelo Pink Sheet
If you are still planning to invest in Evelo Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Evelo Biosciences' history and understand the potential risks before investing.
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |